Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
34.8M
-
Shares change
-
-1.25M
-
Total reported value, excl. options
-
$919M
-
Value change
-
-$30.1M
-
Put/Call ratio
-
0.62
-
Number of buys
-
86
-
Number of sells
-
-66
-
Price
-
$26.43
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q3 2022
189 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.8M shares
of 51.1M outstanding shares and own 67.99% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.55M shares), VANGUARD GROUP INC (4.27M shares), JPMORGAN CHASE & CO (4.05M shares), STATE STREET CORP (2.62M shares), Redmile Group, LLC (1.92M shares), RTW INVESTMENTS, LP (1.85M shares), DIMENSIONAL FUND ADVISORS LP (1.25M shares), Aquilo Capital Management, LLC (968K shares), GEODE CAPITAL MANAGEMENT, LLC (708K shares), and FIRST MANHATTAN CO (706K shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.